# Contact Peptide Supplied — Editorial Desk

> Reach the Peptide Supplied editorial desk regarding citations, corrections, or research-related correspondence about our Metabolic & Weight Research peptide digest.

Correspondence on citations, corrections, and research questions — the only things a reference desk should receive.

## Editorial correspondence

Peptide Supplied accepts correspondence on the research record: a citation that has been quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study about retatrutide, tesamorelin, or MOTS-c that belongs in the [references list](/references). Corrections that improve the factual accuracy of the digest are the most useful messages we receive and are read carefully.

The most actionable notes specify three things: the page in question, the exact passage at issue, and the supporting citation — a DOI or PubMed ID wherever possible. That format lets us verify a proposed change quickly against the source.

**Editorial mailbox:** editors@peptidesupplied.com

## What this desk cannot do

Peptide Supplied is a literature digest — not a clinic, not a pharmacist, and not a vendor. That means we cannot:

- Advise on, recommend, or comment on human use of any peptide discussed here.
- Suggest a dose, schedule, reconstitution method, or route of administration for any individual.
- Diagnose a condition or assess whether a research finding applies to a particular person.
- Sell, source, recommend, or help locate retatrutide, tesamorelin, MOTS-c, or any other compound from any supplier.
- Answer requests from competitive athletes about these compounds, several of which are prohibited in sport.

Readers seeking medical guidance should consult a licensed clinician operating in their own jurisdiction and working with regulated, evidence-based options. Editorial correspondence is monitored intermittently and responses are not guaranteed.

---

A practitioner's reading desk for metabolic peptide research — citations and mechanism, not doses and not advice.